Vmbook Online ordering

Human Pheromone Sciences Inc

I assume you are referring to the company "Human Pharmaceutical Sciences Inc." (HPSI), which trades over-the-counter (OTC) in the USA under the symbol HPSI. The company operates in the personal products industry, focusing on the research, development, and production of human pheromone-based products. Here's some general information about HPSI:

1. Stock Price & Market Capitalization: At the time of writing, the HPSI stock price is around $0.01 per share, resulting in a market capitalization of approximately $1.4 million. It is essential to note that stock prices and market capitalization are subject to change frequently.

2. Earnings & Revenue: HPSI has not reported positive net earnings since its inception. Their revenue has remained minimal and volatile over the years. Q3 2021 reports showed a net loss of $1,763,061, compared to a net loss of $881,580 in Q3 2020. It is essential to conduct thorough research and keep up-to-date with their recent financial statements for accurate information.

3. Growth: HPSI's growth has been limited and inconsistent. As a development-stage company in the personal products industry, the company's primary challenge is converting research and development efforts into commercially viable products and generating sufficient revenue.

4. Dividends: HPSI does not pay dividends, as it is a development-stage company focusing on growth and research projects.

5. Management: Find information about HPSI's management team, board of directors, and important shareholders. It would help if you considered their track records and experience in the personal products industry or related fields.

Investors should be cautious when investing in development-stage companies like HPSI, as they typically involve higher risks than established companies in the market. Thorough research should be conducted, including analysis of current financial statements, market trends, and the competitive landscape. Additionally, prospective investors should consider seeking advice from a financial advisor or investment professional before making investment decisions.